102 related articles for article (PubMed ID: 25510596)
21. Magnetic resonance angiography reveals increased arterial blood supply and tumorigenesis following high fat feeding in a mouse model of triple-negative breast cancer.
Mustafi D; Valek R; Fitch M; Werner V; Fan X; Markiewicz E; Fernandez S; Zamora M; Mueller J; Olopade OI; Conzen SD; Brady MJ; Karczmar GS
NMR Biomed; 2020 Oct; 33(10):e4363. PubMed ID: 32881124
[TBL] [Abstract][Full Text] [Related]
22. Conservative surgery for multifocal/multicentric breast cancer.
Nijenhuis MV; Rutgers EJ
Breast; 2015 Nov; 24 Suppl 2():S96-9. PubMed ID: 26303986
[TBL] [Abstract][Full Text] [Related]
23. MRI of the breast as part of the assessment in population-based mammography screening.
Bick U; Engelken F; Diederichs G; Dzyuballa R; Ortmann M; Fallenberg EM
Rofo; 2013 Sep; 185(9):849-56. PubMed ID: 23740312
[TBL] [Abstract][Full Text] [Related]
24. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
[TBL] [Abstract][Full Text] [Related]
25. [Whole-body MRI in preoperative diagnostics of breast cancer--a comparison with [corrected] staging methods according to the S 3 guidelines].
Hausmann D; Kern C; Schröder MT; Sütterlin M; Schönberg SO; Neff KW; Dinter DJ
Rofo; 2011 Dec; 183(12):1130-7. PubMed ID: 22068844
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging of breast cancer: factors affecting the accuracy of preoperative lesion sizing.
Mennella S; Garlaschi A; Paparo F; Perillo M; Celenza M; Massa T; Rollandi GA; Garlaschi G
Acta Radiol; 2015 Mar; 56(3):260-8. PubMed ID: 24526754
[TBL] [Abstract][Full Text] [Related]
27. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
28. Reflectance confocal microscopy for characterization of mammary ductal structures and development of neoplasia in genetically engineered mouse models of breast cancer.
Parrish A; Halama E; Tilli MT; Freedman M; Furth PA
J Biomed Opt; 2005; 10(5):051602. PubMed ID: 16292950
[TBL] [Abstract][Full Text] [Related]
29. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
Wiechmann L; Kuerer HM
Cancer; 2008 May; 112(10):2130-42. PubMed ID: 18383519
[TBL] [Abstract][Full Text] [Related]
30. Defining an optimal role for breast magnetic resonance imaging when evaluating patients otherwise eligible for accelerated partial breast irradiation.
Horst KC; Fero KE; Ikeda DM; Daniel BL; Dirbas FM
Radiother Oncol; 2013 Aug; 108(2):220-5. PubMed ID: 23597699
[TBL] [Abstract][Full Text] [Related]
31. Quantitative apparent diffusion coefficient as a noninvasive imaging biomarker for the differentiation of invasive breast cancer and ductal carcinoma in situ.
Bickel H; Pinker-Domenig K; Bogner W; Spick C; Bagó-Horváth Z; Weber M; Helbich T; Baltzer P
Invest Radiol; 2015 Feb; 50(2):95-100. PubMed ID: 25333308
[TBL] [Abstract][Full Text] [Related]
32. Targeting difficult accessible breast lesions: MRI-guided needle localization using a freehand technique in a 3.0 T closed bore magnet.
Meeuwis C; Peters NH; Mali WP; Gallardo AM; van Hillegersberg R; Schipper ME; van den Bosch MA
Eur J Radiol; 2007 May; 62(2):283-8. PubMed ID: 17218074
[TBL] [Abstract][Full Text] [Related]
33. BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ.
Tozaki M
Breast Cancer; 2013 Jan; 20(1):13-20. PubMed ID: 22109641
[TBL] [Abstract][Full Text] [Related]
34. MR-guided vacuum-assisted breast biopsy: is it an essential technique?
Tozaki M; Yamashiro N; Suzuki T; Kawano N; Ozaki S; Sakamoto N; Abe S; Ogawa T; Katayama N; Tsunoda Y; Fukuma E
Breast Cancer; 2009; 16(2):121-5. PubMed ID: 18807122
[TBL] [Abstract][Full Text] [Related]
35. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
[TBL] [Abstract][Full Text] [Related]
36. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
[TBL] [Abstract][Full Text] [Related]
37. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
Arazi-Kleinman T; Causer PA; Jong RA; Hill K; Warner E
Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
[TBL] [Abstract][Full Text] [Related]
38. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.
Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
AJR Am J Roentgenol; 2003 Apr; 180(4):901-10. PubMed ID: 12646427
[TBL] [Abstract][Full Text] [Related]
39. [MRI outstands mammogram in sensitivity of breast ductal carcinoma in situ:an analysis of 122 cases].
Yu QX; Chen XS; Wu JY; Han BS; He JR; Zhu L; Chen WG; Li YF; Tan L; Chai WM; Wang DB; Fei XC; Yuan F; Jin XL; Shen KW; Li HW
Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):26-9. PubMed ID: 23578423
[TBL] [Abstract][Full Text] [Related]
40. Elevated expression of the tumor suppressing protein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer.
Lawson JS; Tran DD; Ford C; Rawlinson WD
Breast Cancer Res Treat; 2004 Sep; 87(1):13-7. PubMed ID: 15377846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
